Limb Load Biofeedback Training for Osseointegration
(TOPLOAD Trial)
Trial Summary
What is the purpose of this trial?
This randomized controlled trial (n=25 enrolled, n=15 expected to complete) will 1) determine the feasibility of a 40-week limb-load biofeedback training intervention, 2) determine if there is an intervention signal of efficacy, and 3) identify functional movement priorities for people with transfemoral osseointegrated (OI) prostheses. A limb-load biofeedback training group (EXP (n=10)) will be compared to a standard of care attention-control group without limb-load biofeedback training (CTL (n=5)). Outcomes will be assessed at standard of care pre-habilitation end (Week 5), standard of care rehabilitation end (Week 24), and one year after OI Stage 2 surgery (Week 64).
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Limb Load Biofeedback Training for Osseointegration?
Research shows that biofeedback, including audio biofeedback, helps people with amputations better control weight-bearing activities, preventing overload on the limb. This suggests that Limb Load Biofeedback Training could be effective in helping patients with osseointegrated prostheses manage their limb load more accurately during rehabilitation.12345
Is Limb Load Biofeedback Training generally safe for humans?
How is Limb Load Biofeedback Training for Osseointegration different from other treatments?
Limb Load Biofeedback Training for Osseointegration is unique because it uses real-time feedback to help patients monitor and adjust the weight they place on their prosthetic limb, which can prevent overloading and improve rehabilitation outcomes. This approach is different from traditional methods that rely on static measurements, like a bathroom scale, which do not provide continuous feedback during movement.125910
Research Team
Cory Christiansen, PhD
Principal Investigator
University of Colorado, Denver
Eligibility Criteria
This trial is for adults over 18 with a single below-knee amputation from trauma, birth defects, or cancer. They should have had issues with prosthetic sockets and be scheduled for osseointegration surgery. It's not open to those with substance abuse, unstable heart conditions, vascular-related amputations, infections, cognitive impairments (MoCA score <24), or active cancer treatment.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-habilitation
Standard of care pre-habilitation before surgery
Rehabilitation
Standard of care rehabilitation and limb-load biofeedback training
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term Follow-up
Assessment of outcomes one year after OI Stage 2 surgery
Treatment Details
Interventions
- Attention Control
- Limb Load Biofeedback Training Intervention
Limb Load Biofeedback Training Intervention is already approved in United States, European Union for the following indications:
- Rehabilitation of transfemoral amputees with osseointegrated prostheses
- Rehabilitation of transfemoral amputees with osseointegrated prostheses
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor
United States Department of Defense
Collaborator